Evidence map›Paper›PMID 33680719›Full record

ArticlePreventive medicine reports2021

Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics.

Clare A Aitken, Sylvia Kaljouw, Albert G Siebers, Matilde Bron, Anne Morssink, Folkert J van Kemenade, Inge M C M de Kok

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Exploring the role of the oncology nurse in cervical cancer screening programs during times of transition.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  15. Organized Breast and Cervical Cancer Screening: Attendance and Determinants in Rural China.International journal of environmental research and public health · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Clare A AitkenDepartment of Public Health, Erasmus MC University Medical Center, Dr. Molewaterplein 40, 3015 CN Rotterdam, the Netherlands.
Sylvia KaljouwDepartment of Public Health, Erasmus MC University Medical Center, Dr. Molewaterplein 40, 3015 CN Rotterdam, the Netherlands.
Albert G SiebersPALGA, the Nationwide Network and Registry of Histo- and Cytopathology in the Netherlands, Randhoeve 225A, 3995 GA Houten, the Netherlands.
Matilde BronBevolkingsonderzoek Noord, Queridolaan 5, 9721 SZ Groningen, the Netherlands.
Anne MorssinkBevolkingsonderzoek Oost, Zutphenseweg 51, 7418 AH Deventer, the Netherlands.
Folkert J van KemenadeDepartment of Pathology, Erasmus MC University Medical Center, Dr. Molewaterplein 40, 3015 CN Rotterdam, the Netherlands.
Inge M C M de KokDepartment of Public Health, Erasmus MC University Medical Center, Dr. Molewaterplein 40, 3015 CN Rotterdam, the Netherlands.
Erasmus MC · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Declining attendance in the Dutch cervical cancer screening programme was recently observed, coinciding with preparations for implementing primary hrHPV-based screening, which was implemented in January 2017. We aimed to investigate which factors were related to decreased attendance. We conducted a population-based cohort study including all women aged 30 to 60 years who were eligible for screening between 2014 and 2018. Attendance was defined as participation in the screening programme within 15 months of the start of the invitation-eligible year. We used data from the Dutch pathology archive (PALGA) linked with data from Statistics Netherlands to investigate population characteristics (position in the household, household income, socio-economic status, number of people in the household, migration background, age) and data from the five Dutch screening organisations (SO) to investigate the effect of cessing self-inviting GP's ('inviting organisation'). SO's were termed SO 1 to 5. Higher attendance rates were observed in women who were employed (60.8%), married (62.9%), Dutch (61.2%), in the highest income bracket (63.4%), living in households with four persons (65.3%) and women who were invited by their GP (69.8%). Differences in personal characteristics did not explain the decline in attendance rates. By adjusting for whether the GP or the SO sent the invitation, the differences in attendance rates between 2014 and 2015 and 2016 and between 2014 and 2015 and 2017-2018 were explained in some screening organisations. Removing the possibility for GPs to send invitations explains some of the decline in participation, although this did not account for the total change in attendance.

Indexed as

CBS, Statistics NetherlandsCervical cancer screeningGP, general practitionerOrganised screeningPALGA, The nationwide network and registry of histo- and cytopathology in the NetherlandsRR, relative riskScreening attendanceSO, screening organisation

Identifiers

PMID33680719
PMCPMC7930587
OpenAlexW3131420833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.